期刊文献+

tau蛋白和β-淀粉样蛋白在阿尔茨海默病病理过程中作用及自噬机制的研究概况 被引量:8

Research situation of tau proteins and β-amyloid protein in the pathological process and autophagic mechanisms in Alzheimer′s disease
原文传递
导出
摘要 阿尔茨海默病(AD)是引起老年痴呆最常见的一种神经退行性疾病。tau蛋白和β-淀粉样蛋白(Aβ)(1-42)的错误折叠和积聚引起进行性神经元丢失。目前观点认为,AD主要的生物学标志tau蛋白和Aβ能够反映其病理特征,即反映神经元外神经元纤维缠结和神经元内老年斑的沉积。自噬是一种高度保守的溶酶体依赖性的降解程序,可以为机体供能、清理代谢废物、平衡免疫炎症反应等。笔者概述tau蛋白和Aβ在AD病理过程中的作用及自噬机制的研究现状。 Alzheimer′s disease(AD) is a neurodegenerative disease which is the most common form of dementia in the elderly. Misfolding and accumulation of tau proteins and β-amyloid (Aβ)(1-42) cause progressive neuronal loss. In recent researches, the biological markers of AD, tau proteins and β-amyloid protein, could reflect its pathological features as including neuronal fiber tangles (NFTs) and senile plaque (SP) deposition in neurons. Autophagy is a highly conserved lysosomal-dependent degradation process that supplies energy to the body, cleans up metabolic waste, and balances immune inflammatory responses.In this review, we concluded the pathology of tau proteins and Aβ protein and the autophagic mechanisms in AD.
作者 乔蕾 孙寅轶 曲忠森 Qiao Lei;Sun Yinyi;Qu Zhongsen(Department of Neurology,Shanghai Sixth People′s Hospital East Affiliated to Shanghai University of Medicine & Health Science, Shanghai 201306, China)
出处 《中华诊断学电子杂志》 2019年第2期94-97,共4页 Chinese Journal of Diagnostics(Electronic Edition)
基金 上海健康医学院2018年种子基金课题(SFP-18-22-14-004)
关键词 阿尔茨海默病 TAU蛋白质类 淀粉样蛋白 病理 自噬 Alzheimer disease Tau proteins Amyloid Pathology Autophagy
  • 相关文献

参考文献3

二级参考文献38

  • 1陈双庆,蔡庆,沈玉英,赵中,周华.轻度认知功能损害患者扣带后回谷氨酸多体素氢质子磁共振波谱研究[J].中华诊断学电子杂志,2013,1(1). 被引量:33
  • 2李修英,潘雨利,邵立平,高怡红.离退休老干部老年痴呆症患病情况及相关影响因素[J].中国老年学杂志,2014,34(12):3413-3416. 被引量:12
  • 3冯利杰,李琪,方辉,王海萍,粱燕,沈玉先.非神经源性细胞中tau蛋白的稳定表达及磷酸化[J].安徽医科大学学报,2007,42(2):119-123. 被引量:5
  • 4Wimo A, Ballard C, Brayne C, et al. Health economic evaluation of treatments for Alzheimer' s disease: impact of new diagnostic criteria[ J ] .J Intern Med, 2014,275 ( 3 ) : 304-316.
  • 5Murayama S,Saito Y.Neumpathological diagnostic criteria for Alzheimer's disease [ J ].Neuropathology, 2004,24 ( 3 ) : 254-260.
  • 6McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease [ J ]. Neurology, 1984,34 ( 7 ) : 939-944.
  • 7Knopman DS ,DeKosky ST, Cummings JL, et al.Practice parameter: diagnosis of dementia ( an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology[J] .Neurology,2001,56(9) :1143-1153.
  • 8Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease? [J].Lancet Neurol,2004,3(4) :246-248.
  • 9Jack CJ, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[ J].Alzheimers Dement,2011,7(3) :257-262.
  • 10Brayne C.A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease [ J ]. Lancet Neurol, 2014,13 ( 6 ) : 532-534.

共引文献84

同被引文献105

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部